Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SkinHealth SystemsSKIN +2.71%53 Return-on-Tangible-Equity is 0.00% as of Mar. 2026. GuruFocus rates SKIN with a GF Score™ of 53/100 and a GF Value™ of $1.49 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,881 Consumer Packaged Goods companies, SkinHealth Systems ranks worse than 53163.16% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. SkinHealth Systems's annualized net income for the quarter that ended in Mar. 2026 was $-26.5 Mil. SkinHealth Systems's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $-102.6 Mil. Therefore, SkinHealth Systems's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was N/A%.
The historical rank and industry rank for SkinHealth Systems's Return-on-Tangible-Equity or its related term are showing as below:
During the past 8 years, SkinHealth Systems's highest Return-on-Tangible-Equity was 74.53%. The lowest was 0.00%. And the median was 74.53%.
SKIN's Return-on-Tangible-Equity is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 7.78 * Ranked among companies with meaningful Return-on-Tangible-Equity only.
SkinHealth Systems (NAS:SKIN) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
SkinHealth Systems Return-on-Tangible-Equity Related Terms
SkinHealth Systems Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for SkinHealth Systems's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SkinHealth Systems Return-on-Tangible-Equity Chart
SKIN vs SLSN, GROV, UG: Return-on-Tangible-Equity Comparison
For the Household & Personal Products subindustry, SkinHealth Systems's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SkinHealth Systems Return-on-Tangible-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, SkinHealth Systems's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where SkinHealth Systems's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.00% mean?
SkinHealth Systems (SKIN) has a Return-on-Tangible-Equity of 0.00% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on SkinHealth Systems and its competitors. According to the industry distribution chart, SkinHealth Systems ranks #999999 out of 1881 companies in the Consumer Packaged Goods industry.
Is SkinHealth Systems' Return-on-Tangible-Equity too high?
SkinHealth Systems' current Return-on-Tangible-Equity is 0.00%. Based on the distribution chart, SkinHealth Systems ranks #999999 out of 1881 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, SkinHealth Systems has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SkinHealth Systems' Return-on-Tangible-Equity compare to SLSN and GROV?
According to the Consumer Packaged Goods industry distribution chart, SkinHealth Systems ranks #999999 out of 1881 companies for Return-on-Tangible-Equity. This places SkinHealth Systems in the lower half of its industry. The industry median Return-on-Tangible-Equity is 7.78. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Consumer Packaged Goods company?
The median Return-on-Tangible-Equity among Consumer Packaged Goods companies is 7.78, based on 1,881 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on SkinHealth Systems and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Equity is 7.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SkinHealth Systems's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SkinHealth Systems stock overvalued right now?
Based on GuruFocus' analysis, SkinHealth Systems (SKIN) is currently considered Possible Value Trap. The stock's GF Value™ is $1.49, compared to a current price of $0.84 — trading 43.4% below its estimated fair value. The current Return-on-Tangible-Equity is 0.00%. SkinHealth Systems' overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For SkinHealth Systems (SKIN), the current Return-on-Tangible-Equity is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SkinHealth Systems (SKIN) Overvalued in 2026?
Based on GuruFocus' analysis, SkinHealth Systems stock appears to be undervalued.
The current stock price of $0.84 is trading 43.4% below its estimated GF Value™ of $1.49.
GuruFocus considers SkinHealth Systems to be Possible Value Trap.
Key valuation signals for SKIN:
Return-on-Tangible-Equity: 0.00%
GF Value™: $1.49 vs. price of $0.84 (43.4% below fair value)
No single metric tells the full story. See the SKIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SkinHealth Systems Inc is a world-wide medical aesthetics company delivering an integrated ecosystem of clinically validated solutions designed to help consumers achieve superior skin health and support the success of providers. Its brands are Hydrafacial and SkinStylus.
53GF Score
Get the complete analysis for SKIN
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SKIN has been successfully added to your 
